Palmetto innovasphere leadership

Cecilia is a founder, an entrepreneur and executive.  She has held leadership positions in strategy, joint venture, startup development, program administration and experience with mergers and acquisitions.  Her career spans more than 30+ years in life science/biotechnology and healthcare industry.  Cecilia started her tenure as a strategic planner under the direction of Dr. Robert Day, then President of Fred Hutchinson Cancer Research in the early 1990s.  She then became Division Program  Administrator for the Molecular Pharmacology, Clinical Research Division under the leadership of Dr.Lee Hartwell and Dr. Stephen Friend.  Cecilia held the position of Director of Strategic Development and as the Director of Affiliate Network and Strategic Outreach, overseeing all clinical research partnerships with community cancer centers in Alaska, Washington, Idaho, Montana and Hawaii.  In the summer of 2017, Cecilia decided to return to her life science and biotechnology roots and started a new company 3rdeEyeBio, LLC as one of the Managing Partners.  3rdEyeBio, LLC is an accelerator group providing life science/biotech startups the infrastructure to support overall growth from scientific advisory to investment raise. Has held the role of CBIO for Vyrty Corporation dba SyncMD, located in Anderson, South Carolina, a multi-dimensional technology company.

She is founder and executive director of Women, Life and Science, Inc., a board member for the Luskin Famlly Foundation.

With over 25 years of experience in the life sciences industry spanning both profit and non-profit sectors, Lillia is known for utilizing her scientific research foundation to benefit companies with complex operations. Her commitment to advancing healthcare innovation and improving patient outcomes is fueled by her passions: growing life science companies (especially in South Carolina), oncology and blood donation.  Most recently, Lillia served as the Chief Operating Officer of Kiyatec, where she played a pivotal role in execution of corporate strategy along with oversight and expansion of operations to establish their CLIA certified laboratory leading to clinical studies and subsequent commercial availability of their functional precision oncology diagnostic.  Her multifaceted experience in prior positions at The Blood Connection, the Oncology Research Institute of Greenville Hospital System and Greenwood Genetic Center developed her operational skills and regulatory affairs expertise which enabled her to become a trusted leader known for quality management and operational efficiency. She holds a Master of Science degree in Biomedical Sciences from East Tennessee State University and is a Board Member of Women, Life and Science. 

Wes started his professional career as an auditor for Ernst & Young, LLP working his to having over 20 years as Controller and CFO roles for diverse companies including extensive experience in the life science industry.  He is currently Partner at Ethan Rivers Firm in Greenville, SC.